Landiolol, an ultra-short-acting β?-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1097-1101
Number of pages5
JournalCirc J
Volume76
Publication statusPublished - 2012

Cite this